ExactAntigen

NKG2D antibody | antibody review based on formal publications
KLRK1 antibodies
This is a review about NKG2D antibodies, based on 1 published article using NKG2D antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited NKG2D antibody.
R & D Systems    search R & D Systems KLRK1 products
blockIn some experiments CIK cells were mixed with NKG2D blocking antibody (20 μg/ml for 30 mins) (R&D Systems, Minneapolis) prior to addition to target cells. to the paper
BD Biosciences    search BD Biosciences KLRK1 products
flowCells were then stained with cell surface markers including anti-MHC Class I polypeptide-related sequence A/B (MICA/B) antibody conjugated to PE at a dilution of 1:200, anti-mouse CD3-FITC at 1:50, anti-mouse DX5-PE at 1:50, anti-human CD3-PerCPCy5.5 at 1:20, anti-human CD56-APC at 1:100, anti-human CD16-PE at 1:100, anti-vaccinia polyclonal-FITC at 1:200, anti-mouse NKG2D-PE at 1:50 and anti-human NKG2D-APC at 1:100 (all antibodies from BD Pharmingen, San Diego; Abcam, Cambridge; or eBioscience, San Diego). to the paper
Articles Reviewed
1:Steve H Thorne et al. Synergistic antitumor effects of immune cell-viral biotherapy. 2006


2008©ExactAntigen home | browse | about